Evidence map›Paper›PMID 31299893›Full record

ArticleBMC infectious diseases2019

Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis.

Roshanthi Eranga Karunaratne, Lahiru A Wijenayaka, Sandya Sulochana Wijesundera, K M Nalin De Silva, Chamila Priyangani Adikaram, Jennifer Perera

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Revisiting the methods for detectingAccess microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Roshanthi Eranga KarunaratneDepartment of Microbiology, Faculty of Medicine, University of Colombo, box 271, Kynsey Road, Colombo, PO, 08, Sri Lanka. erangark@yahoo.com.ORCID http://orcid.org/0000-0002-9829-6641
Lahiru A WijenayakaSri Lanka Institute of Nanotechnology (SLINTEC), Mahenwatte, Pitipana, Homagama, Sri Lanka.
Sandya Sulochana WijesunderaDepartment of Molecular Biology and Biochemistry, Faculty of Medicine, University of Colombo, Colombo, 08, Sri Lanka.
K M Nalin De SilvaSri Lanka Institute of Nanotechnology (SLINTEC), Mahenwatte, Pitipana, Homagama, Sri Lanka.
Chamila Priyangani AdikaramCentral Public Health Laboratories, National Tuberculosis Reference Laboratory, Ministry of Health, Muscat, Sultanate of Oman.
Jennifer PereraDepartment of Microbiology, Faculty of Medicine, University of Colombo, box 271, Kynsey Road, Colombo, PO, 08, Sri Lanka.
University of Colombo · LKMinistry of Health · OMOpen University of Sri Lanka · LKSri Lanka Institute of Nanotechnology · LK

Funding

National Research Council Sri Lanka NRC 12-140
6 · The paper itself

Abstract

backgroundThe increased transmission of multidrug-resistant (MDR) tuberculosis (TB) poses a challenge to tuberculosis prevention and control in Sri Lanka. Isoniazid (INH) is a key element of the first line anti tuberculosis treatment regimen. Resistance to INH may lead to development of MDR TB. Therefore, early detection of INH resistance is important to curb spread of resistance. Due to the limited availability of rapid molecular methods for detection of drug resistance in Sri Lanka, this study was aimed at developing a simple and rapid gold nanoparticle (AuNP) based lateral flow strip for the simultaneous detection of the most common INH resistance mutation (katG S315 T, 78.6%) and Mycobacterium tuberculosis (MTb).

methodsLateral flow strip was designed on an inert plastic backing layer containing a sample pad, nitrocellulose membrane and an absorption pad. Biotin labeled 4 capture probes which separately conjugated with streptavidin were immobilized on the nitrocellulose. The test sample was prepared by multiplex PCR using primers to amplify codon 315 region of the katG gene and MTb specific IS6110 region. The two detection probes complementary to the 5' end of each amplified fragment was conjugated with gold nanoparticles (20 nm) and coupled with the above amplified PCR products were applied on the sample pad. The hybridization of the amplified target regions to the respective capture probes takes place when the sample moves towards the absorption pad. Positive hybridization is indicated by red colour lines.

resultsThe three immobilized capture probes on the strip (for the detection of TB, katG wild type and mutation) were 100 and 96.6% specific and 100 and 92.1% sensitive respectively.

conclusionThe AuNP based lateral flow assay was capable of differentiating the specific mutation and the wild type along with MTb identification within 3 h.

Indexed as

Antitubercular AgentsBacterial ProteinsCatalaseCommunicable DiseasesDNA, BacterialGoldHumansIsoniazidLimit of DetectionMetal NanoparticlesMultiplex Polymerase Chain ReactionMycobacterium tuberculosisNanotechnologySri LankaTuberculosis, Multidrug-ResistantAntitubercular AgentsBacterial ProteinsCatalaseDNA, BacterialGoldIsoniazidkatG protein, Mycobacterium tuberculosisGold nanoparticlesIsoniazidMDR TBMycobacterium tuberculosis

Identifiers

PMID31299893
PMCPMC6626415
OpenAlexW2961573450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.